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with RLS. In our study, we excluded all patients 
with a serum ferritin level of less than 15 μg per 
liter (see the protocol, available at NEJM.org).
Unfortunately, intravenous iron treatments 
have not been adequately evaluated to establish 
them as a standard treatment for RLS. Data from 
a small controlled positive study of ferric carboxy-
maltose3 and from two negative studies of iron 
sucrose4,5 are available. The differences here may 
reflect effects of different formulations of iron 
or random variation around a small treatment 
benefit. Data are lacking from controlled clinical 
studies of intravenous iron treatment for RLS to 
support the recommendation of this approach.
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Multiple Phenotypes in Phosphoglucomutase 1 Deficiency
To the Editor: Tegtmeyer et al. (Feb. 6 issue)1 
state that patients with phosphoglucomutase 1 de-
ficiency are susceptible to malignant hyperther-
mia along with multiple other clinical manifesta-
tions, including myopathy, rhabdomyolysis, and 
dilated cardiomyopathy. Might the authors clarify 
their diagnostic criterion for malignant hyper-
thermia in the two patients in whom “severe 
rhabdomyolysis” developed after general anes-
thesia was administered? Pronounced rhabdomy-
olysis distinct from malignant hyperthermia may 
develop in patients with myopathies such as 
Duchenne’s muscular dystrophy when they are 
exposed to volatile anesthetic gases.
Virgil M. Airola, M.D.
Children’s Hospital Central California 
Madera, CA
No potential conflict of interest relevant to this letter was re-
ported.
1. Tegtmeyer LC, Rust S, van Scherpenzeel M, et al. Multiple 
phenotypes in phosphoglucomutase 1 deficiency. N Engl J Med 
2014;370:533-42.
DOI: 10.1056/NEJMc1403446
The Authors Reply: In phosphoglucomutase 1 de-
ficiency, general anesthesia has been shown to 
induce rhabdomyolysis and high fever. In our 
first patient, surgery for cleft palate was per-
formed at 1.5 years of age. Halothane was used 
for anesthesia. Because unexplained acidosis with 
an increased partial pressure of carbon dioxide, 
a base excess of −9 mmol per liter, and fever de-
veloped in the patient, we assessed the plasma 
creatine kinase level, which increased from 700 U 
per liter 2 hours after surgery to more than 
10,000 U per liter a few hours later. The serum 
myoglobin level was 178 μg per liter. The clinical 
grading scale to predict malignant hyperthermia 
(on a scale from 0 to 88, with scores higher than 
50 indicating malignant hyperthermia) showed a 
raw score of 68 and the highest rank of 6,1 indi-
cating an almost certain likelihood of malignant 
hyperthermia. When the patient was 4 years of 
age and again at 18 years of age, “trigger-free” 
anesthesia (without drugs known to induce ma-
lignant hyperthermia) with propofol and remifen-
tanil used together led to minor increases in the 
creatine kinase level without fever. No depolar-
izing muscle relaxants had been used. We are 
aware of the ongoing discussion regarding wheth-
er or not rhabdomyolysis in disorders such as 
Duchenne’s muscular dystrophy is similar to 
malignant hyperthermia.2,3
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Fundamentals of Lung Auscultation
To the Editor: We wish to complain (râler in 
French slang)1 that Bohadana and colleagues 
(Feb. 20 issue)2 have breathed life into the term 
“rhonchus,” which is as redundant as terms such 
as “phthisis.” Robertson and Coope3 suggested 
that lung sounds be divided primarily into con-
tinuous sounds, which they labeled wheezes, and 
interrupted (discontinuous) sounds, which they 
called crackles. Forgacs4 emphasized that wheez-
es are musical and crackles are not. The binary 
distinction is easy to teach and to use in practice. 
Bohadana et al. describe the rhonchus as a vari-
ant of the wheeze, indicate that its frequency is 
approximately 150 Hz, and liken it to snoring. 
Earlier distinctions between mucous, sibilant, and 
sonorous rhonchi5 are ignored; the frequency of 
wheeze — 100 to almost 5000 Hz — encom-
passes 150 Hz; since snores are inspiratory and 
rhonchi are usually expiratory, this might be mis-
leading. It is time to dispense with “rhonchus” as 
well as with “rale” (which means “death rattle”).1
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To the Editor: The review of lung auscultation 
has two easily overlooked lessons that are par-
ticularly important in the examination of chil-
dren.1 First, no noise is pathognomonic of a par-
ticular disease (or anatomical site). For example, 
stridor is not diagnostic of laryngeal obstruction. 
Obstruction at other sites can mimic the sound. 
Second, the “musical” sounds of airway obstruc-
tion — stridor, wheeze, stertor, and snore — 
form part of a continuous sound spectrum and 
cannot be distinguished from one another by 
means of any objective criterion. Their frequency 
spectra overlap, and their waveforms lack unique 
features. What matters most in children is not 
whether a noise can be called snoring, stridor, or 
wheeze but whether the sound is inspiratory or 
expiratory.
Airway obstruction above the chest is worst 
and noise is loudest during inspiration. By con-
trast, intrathoracic airway obstruction is worst 
and noise is loudest during expiration. The site 
of airway obstruction in children with noisy 
breathing can be pinpointed by answering only 
two questions — without having to put a name 
to any sound. First, is airway obstruction worse 
during inspiration or expiration? Depending on 
the answer to the first question, the second 
question is either “Does obstruction occur when 
the child is breathing through the mouth or cry-
ing?” or “Is bilateral air trapping present?” The 
figure in the Supplementary Appendix, available 
with the full text of this letter at NEJM.org, 
shows an algorithm of the diagnostic process.
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